Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Non-catechol aporphine compound as well as pharmaceutic composition and application thereof

A catechol aporphine compound technology, applied in the field of non-catechol aporphine compounds, can solve problems such as involuntary movements, monotony and rigidity

Inactive Publication Date: 2010-09-29
SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Moreover, after chronic medication, many PD patients (40% to 60%) have adverse reactions such as severe involuntary movement or dyskinesia. The patient shows involuntary movement, which can involve the head, face, limbs and trunk, and sometimes appears monotonous and stereotyped. and involuntary movements or dystonia necessitating discontinuation of treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Non-catechol aporphine compound as well as pharmaceutic composition and application thereof
  • Non-catechol aporphine compound as well as pharmaceutic composition and application thereof
  • Non-catechol aporphine compound as well as pharmaceutic composition and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a non-catechol aporphine compound as well as a pharmaceutic composition and application thereof, in particular to a non-catechol aporphine compound shown as a general formula (I) or a stereoisomer thereof, a pharmaceutically acceptable salt or a pharmaceutically acceptable solvate and medical application thereof. The compound can be used for preventing or treating diseases related with serotonin 1A receptors, comprising central nervous system diseases, particularly schizophrenia, depressions and dyskinesia caused by medicaments for resisting parkinson's diseases. The invention also relates to the medical composition containing the compound.

Description

technical field The present invention relates to non-catechol aporphine compounds, which have higher activity on serotonin 1A receptors, and therefore can be used in various therapeutic fields, especially in the treatment of diseases of the central nervous system, such as schizophrenia, Depression and movement disorders caused by anti-Parkinson's disease drugs, etc. The present invention also relates to pharmaceutical compositions comprising the compounds described above. Background technique 1. Five serotonin 1A receptors Five serotonin (5-HT) is an important central neurotransmitter. The synthesis, storage, membrane uptake and metabolism of 5-HT together with the 5-HT receptor constitute the 5-HT nervous system. Currently, at least seven types of 5-HT receptors have been cloned, namely 5-HT 1 ~5-HT 7 . Some have several subtypes. Drugs acting on the 5-HT system are used to treat various mental diseases such as schizophrenia and depression, obesity, and sexual dysfu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D221/18C07D491/06A61K31/473A61K31/4741A61P25/28A61P25/18A61P25/14A61P25/24
Inventor 张翱镇学初刘志礼张海
Owner SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com